Zoe Littlepage
Partner | Littlepage Booth
Zoe Littlepage is a mass torts, defective drugs and medical products and human rights and environmental damage trial lawyer and partner at Littlepage Booth in Houston, Texas. J.D., University of Houston Law Center (1990).
Meet Zoe
Zoe Littlepage is a Houston, Texas trial lawyer at Littlepage Booth who represents plaintiffs in mass tort, defective drug, defective medical product and human rights cases. She has tried cases in courts across the country.
Her firm bio lists jury verdicts in hormone replacement therapy cases, Rezulin cases and a 2022 defective swing gate case, among others. She led the state court Rezulin litigation and tried five of the nine Rezulin trials nationwide. In 2003 she was appointed lead counsel of the Plaintiffs’ Steering Committee in the Hormone Replacement Therapy MDL, and she now holds a position on the Plaintiffs’ Executive Committee in the Acetaminophen (Tylenol) ASD/ADHD MDL, where she also heads the settlement committee.
Littlepage earned a bachelor’s degree from Rice University in 1987 and a law degree with honors from the University of Houston in 1990, where she served on the Houston Law Review. She was inducted into the Inner Circle of Advocates in 2011, received the American Bar Association Tort Trial and Insurance Practice Section’s Pursuit of Justice Award in 2015 and serves as a peer review editor for Trial magazine. She has also taught as an adjunct professor at the University of Houston Law Center.
Experience and Expertise
Qualifications
Timeline
- Rice University, B.A. in English, Psychology and German (1987)
- University of Houston Law Center, J.D., with honors (1990)
- Plaintiffs' Steering Committee, Viagra Blindness Litigation, MDL 1724 (2006)
- Lead Counsel, Hormone Therapy Litigation, MDL 1507 (2003-2014)
- Plaintiffs' Executive Committee and Head of Settlement Committee, Acetaminophen (Tylenol) ASD/ADHD MDL 3043
Practice Areas
- Inner Circle of Advocates (Member, inducted 2011)
- National Women Trial Lawyers Association (Executive Committee Member, 2013-2014)
- Public Citizen (Executive Committee Member, 2013-2014)
- University of Houston Law Center Blakely Advocacy Institute (Advisory Board, 2003)
- Inner Circle of Advocates induction (2011)
- Texas Super Lawyers nominee (2011-present)
- American Bar Association TIPS Section Pursuit of Justice Award (2015)
- Top 25 Mass Tort Trial Lawyers in Texas (2018)
- Lawdragon 500 Leading Plaintiff Consumer Lawyers (2021)
- The National Trial Lawyers Top 100 Civil Plaintiff Trial Lawyers (2023)
- The National Trial Lawyers America's 50 Most Influential Trial Lawyers (2016-2017)
- Clarence Darrow Award for Best Mass Tort Lawyer, Mass Torts Made Perfect (2008)
- Fortune magazine America's Premiere Lawyers (2007)
- American Lawyer Top Lawyers of the Year (2007)
- $10.5 Million Verdict: December 2022 defective swing gate verdict in Utah (Michaud). Appeal dismissed and verdict paid in full, per firm bio.
- $99 Million Punitive Verdict: September 2007 Nevada hormone replacement therapy breast cancer verdict (Rowatt, Scofield, Forrester) of $35 million compensatory and $99 million punitive damages, remitted to $22.6 million compensatory and $35 million punitive, affirmed on appeal and paid in full.
- $75 Million Punitive Verdict: October 2009 Pennsylvania hormone replacement therapy breast cancer verdict (Barton) of $3.74 million compensatory and $75 million punitive damages, remitted to $12 million, affirmed on appeal and paid.
- $28 Million Punitive Verdict: November 2009 Pennsylvania hormone replacement therapy breast cancer verdict (Kendall) of $6.3 million compensatory and $28 million punitive damages, affirmed on appeal and paid.
- $21 Million Punitive Verdict: December 2001 Missouri Rezulin liver failure verdict (Griggs) of $3.2 million compensatory and $21 million punitive damages. Settled.
- $10 Million Punitive Verdict: March 2002 Oklahoma Rezulin liver failure and death verdict (Wakefield) of $1.55 million compensatory and $10 million punitive damages, affirmed on appeal and paid in full.
- $9.45 Million Verdict: February 2010 Pennsylvania hormone replacement therapy breast cancer verdict (Singleton) of $3.45 million compensatory and $6 million punitive damages, affirmed on appeal and paid.
Print is Alive
Trial Lawyer's Journal sets a new standard for law journal publications. With limited ads and one-of-a-kind content, it was created to celebrate wins both in and outside the courtroom.